Regenxbio Inc (RGNX)

EBITDA Margin

-79.73%

TTM · Period ending:

RGNX logo

RGNX EBITDA Margin

Latest reported-79.73%
RGNX TTM EBITDA Margin (12.72% → -79.73%)
High-resolution chart · PNG

RGNX ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Regenxbio Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-79.7314%
-261.1521%
-78.1825%
-74.3854%
-83.4031%
-78.1295%
-237.8888%
-258.3099%
-245.8122%
-273.1568%
-265.3576%
-235.1349%
-251.3839%
-215.1892%
-216.6726%
25.7965%
29.1031%
31.7828%
37.6505%
-190.1135%
-72.6915%
-64.3694%
-62.6473%
-67.369%
-235.0193%
-280.0339%
-402.5942%
-155.1695%
-159.4188%
-51.8046%
42.1418%
40.2997%
41.8816%
36.5547%
-704.3106%
-767.1112%
-848.5178%
-1,624.0593%
-1,402.7021%
-682.697%
-465.6845%
-412.4983%
-251.1861%
-317.0198%
-173.7768%
-1.0722%
12.7187%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.